This session will discuss the current understanding of PAD, including its epidemiology, risk factors, pathophysiology, clinical presentation, and diagnosis. Dr. Evans will review the latest AHA/ACC PAD Guidelines, emphasizing the critical role podiatry plays in identifying and managing patients with this progressive vascular disease. In addition, this webinar will introduce ARTAIRA®, a new, cost-effective intermittent pneumatic compression (IPC) device designed for patients battling PAD and diabetic foot ulcers. ARTAIRA® is Medicare-reimbursed and VA-available, offering practices a noninvasive therapy option for both clinical and home-based care. This program is designed to equip podiatrists with the clinical knowledge and practical tools needed to improve vascular outcomes and expand treatment pathways for complex lower-extremity patients.

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.